ClinicalTrials.gg
Drug

Memantine clinical trials

Also written Namenda and Ebixa.

studies test it
198
open now
18
in phase 3
52
first study started
1996

How each study uses Memantine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Memantine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Oct 2003 · NAMENDA · NDA 021487 (FDA, Drugs@FDA)
European Union
15 May 2002 · Ebixa · EMEA/H/C/000463 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Memantine
148
Memantine Hydrochloride
19
memantine HCl
6
Memantine Oral Tablet
5
Memantine Hydrochloride (HCl)
3

Brand

Namenda
70
Ebixa
17
Akatinol
2

Development codes

DIN 02260638
1

In one entry with another drug

Given together, or one or the other

Rivastigmine, memantine
2

Studies by the year they started

196 studies that test it; most in 2005 (22); 1 more planned to start later

Studies that test Memantine, by start year
YearStudies
19961
19971
19991
20001
20022
20033
200412
200522
200617
200717
200810
200914
20107
20115
201210
20134
20148
20155
20163
20173
20189
20196
20204
20219
20225
20234
20246
20254
20263

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
16
Phase 2
71
Phase 3
52
Phase 4
55
No phase
21

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 29 · Other 169

Forest Laboratories (11) · Massachusetts General Hospital (8) · H. Lundbeck A/S (6) · New York State Psychiatric Institute (6) · National Cheng-Kung University Hospital (5) · University of California, San Diego (4) · Stanford University (4) · Mclean Hospital (4)

Often tested with

Tested in the same studies.

Gabapentin (5) · Donepezil (5) · Dextromethorphan (4) · Rivastigmine (4) · Baclofen (3) · Escitalopram (3) · Melatonin (2) · Modafinil (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3, 2 in phase 3

Studies that test Memantine, phase 3 first.

Studies

Open first, then newest update. How each study uses Memantine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 198

See all 198 studies that test Memantine →

Given beside what is tested · 15 — Memantine is usual care or a partner of the new treatment
As the comparator · 3 — what is tested is compared with Memantine

Codes

What other systems call Memantine · ClinicalTrials.gg INT007785

  • MeSH (NLM) D008559MemantineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) W8O17SJF3TMEMANTINEConfirmed FDA, NLM, Wikidata
  • RxNorm 6719Confirmed FDA, Wikidata
  • Wikidata Q412189memantineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C73269MemantineOne source FDA
  • DrugBank DB01043One source Wikidata

Also registered as memantine hydrochloride (UNII JY0WD0UA60 · RxNorm 236685).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.